Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Cerilliant
Harvard Business School
Deloitte
Argus Health
Farmers Insurance
McKesson
Johnson and Johnson

Generated: June 22, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,871,865

« Back to Dashboard

Summary for Patent: 4,871,865
Title: Tricyclic aromatic compounds
Abstract:The present invention relates to compounds of formula I ##STR1## or a salt, ester or amide thereof; wherein R.sup.1 is --CH.sub.2 --CH.sub.2 --, CH.sub.2 --O-- or --O--CH.sub.2 --; R.sup.2 and R.sup.3 are the same or different and are each hydrogen, C.sub.1-4 alkyl or taken together with the nitrogen comprise a nitrogen-containing heterocyclic ring having four to six ring members; R.sup.4 is a single bond or a C.sub.1-7 bivalent aliphatic hydrocarbon group and may be joined to the aromatic ring system at the 2,3,8 or 9 positions; n is 0 to 3, and their use as anithistamine and antiasthma agents.
Inventor(s): Lever, Jr.; O. William (Skillman, NJ), Leighton; Harry J. (Chapel Hill, NC)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Application Number:06/894,306
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,871,865
Patent Claims: 1. A compound of formula (I) ##STR10## or a pharmacologically and pharmaceutically acceptable salt thereof; wherein R.sup.1 is --CH.sub.2 --O--, R.sup.2 and R.sup.3 are the same or different and are each hydrogen or C.sub.1-4 alkyl, R.sup.4 is a C.sub.1-2 bivalent hydrocarbon group and is joined to the aromatic ring system at the 2 position and n is 2.

2. The compound of claim 1 in which R.sup.2 and R.sup.3 are methyl.

3. The compound of claim 1 which is (z-11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acryl ic acid.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Colorcon
Federal Trade Commission
QuintilesIMS
Accenture
Farmers Insurance
Baxter
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.